Voloridge Investment Management’s Fate Therapeutics FATE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-63,903
| Closed | -$224K | – | 1240 |
|
|
2024
Q3 | $224K | Sell |
63,903
-38,392
| -38% | -$134K | ﹤0.01% | 1125 |
|
|
2024
Q2 | $336K | Sell |
102,295
-276,313
| -73% | -$906K | ﹤0.01% | 1143 |
|
|
2024
Q1 | $2.78M | Buy |
+378,608
| New | +$2.78M | 0.01% | 783 |
|
|
2023
Q3 | – | Sell |
-834,324
| Closed | -$3.97M | – | 1456 |
|
|
2023
Q2 | $3.97M | Sell |
834,324
-624,959
| -43% | -$2.97M | 0.02% | 751 |
|
|
2023
Q1 | $8.32M | Buy |
1,459,283
+928,247
| +175% | +$5.29M | 0.04% | 509 |
|
|
2022
Q4 | $5.36M | Buy |
531,036
+8,462
| +2% | +$85.4K | 0.03% | 622 |
|
|
2022
Q3 | $11.7M | Buy |
522,574
+44,421
| +9% | +$995K | 0.06% | 401 |
|
|
2022
Q2 | $11.8M | Buy |
478,153
+259,435
| +119% | +$6.43M | 0.06% | 392 |
|
|
2022
Q1 | $8.48M | Sell |
218,718
-51,402
| -19% | -$1.99M | 0.05% | 462 |
|
|
2021
Q4 | $15.8M | Buy |
270,120
+145,574
| +117% | +$8.52M | 0.09% | 327 |
|
|
2021
Q3 | $7.38M | Buy |
124,546
+114,447
| +1,133% | +$6.78M | 0.05% | 533 |
|
|
2021
Q2 | $876K | Buy |
+10,099
| New | +$876K | 0.01% | 1298 |
|
|
2021
Q1 | – | Sell |
-35,218
| Closed | -$3.2M | – | 1479 |
|
|
2020
Q4 | $3.2M | Buy |
35,218
+7,253
| +26% | +$659K | 0.03% | 584 |
|
|
2020
Q3 | $1.12M | Buy |
+27,965
| New | +$1.12M | 0.01% | 904 |
|
|
2020
Q2 | – | Sell |
-34,166
| Closed | -$759K | – | 1329 |
|
|
2020
Q1 | $759K | Buy |
+34,166
| New | +$759K | 0.02% | 592 |
|